XMSM
GL9
Market cap5.53bUSD
Sep 17, Last price
19.93EUR
1D
-7.56%
1Q
-9.16%
Jan 2017
26.30%
Name
Glanbia PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Glanbia plc functions as a prominent global entity within the nutrition industry. The company is actively involved in the creation and distribution of a wide array of sports and lifestyle nutrition products, available in diverse formats such as powdered supplements, ready-to-eat bars and snacks, and convenient ready-to-drink beverages. Its extensive distribution channels include specialized retail outlets, online platforms, fitness centers, and major commercial avenues like grocery stores, pharmacies, mass merchandisers, and membership clubs. Beyond consumer products, Glanbia is a significant producer and supplier of cheese, various dairy and plant-based nutritional and functional ingredients, and vital vitamin and mineral premixes. The company's operations further extend into areas such as financing, research and development, real estate transactions, receivables management, property leasing, and offering weight management solutions, in addition to other business and management services. Glanbia maintains a strong portfolio of brands, featuring well-known names like OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. The company, which was established in 1964, has its corporate headquarters situated in Kilkenny, Ireland.
Related entities
Subsidiaries (7)
Glanbia Financial Services Unlimited Company
GLANBIA INVESTCHIP LIMITED
Glanbia Meats Society Limited
Glanbia Nutritionals (Ireland) Limited
GLANBIA NUTRITIONALS LIMITED
TIRLÁN PENSION TRUSTEES LIMITED
Glanbia Performance Nutrition Limited
Key people
Martin Keane
Non-Executive Chairman of the Board · since 2018
John Murphy
Non-Executive Vice Chairman of the Board · since 2017
Hugh McGuire
Chief Executive Officer - Global Performance Nutrition · since 2019
Mark A. Garvey
Group Finance Director, Executive Director · since 2014
Brian Phelan
Chief Executive Officer - Glanbia Nutritionals, Executive Director · since 2016
Group Managing Director, Executive Director · since 2013
Michael Patten
Group Human Resources and Corporate Affairs Director · since 2016
Michael Horan
Group Company Secretary · since 2005
Patsy Ahern
Non-Executive Director · since 2018
Vincent Gorman
Non-Executive Director · since 2013
Tom Grant
Non-Executive Director · since 2017
Brendan Hayes
Non-Executive Director · since 2017
Michael I. Keane
Non-Executive Director · since 2010
Non-Executive Independent Director · since 2014
Donard P. Gaynor
Non-Executive Independent Director · since 2013
Senior Non-Executive Independent Director · since 2019
Headquarters & legal address
Leggetsrath Business Park
Carlow Road
Kilkenny, KK R95 YTD5
IE
Carlow Road
Kilkenny, KK R95 YTD5
IE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||